Research Article
Anti-VEGF Treatment of Diabetic Macular Edema: Two-Year Visual Outcomes in Routine Clinical Practice
Table 3
The CRT at baseline, 1 year, and 2 years.
| | CRT, mean ± SD (median; range) (μm) | | Baseline | 1 year | Change from baseline at 1 year | 2 years | Change from baseline at 2 years | value |
| | All eyes (n = 123) | 440.7 ± 132.5 (430; 114–1000) | 368.4 ± 138.21 (350; 50–1500) | −71.8 ± 159.9 (−64.5; −910–720) | 350.4 ± 108.3 (332; 178–800) | −90.4 ± 131.1 (−85; −210–476) | <0.0001 | | Eyes with baseline VA <70 letters (n = 77) | 464.2 ± 143.9 (460; 114–1000) | 384.8 ± 164.6 (350; 50–1500) | −73.2 ± 185.9 (−62; −910–720) | 363.5 ± 110.9 (340; 178–800) | −101 ± 136.8 (−90; −172–440 | <0.0001 | | Eyes with baseline VA ≥70 letters (n = 46) | 401.5 ± 100.5 (410; 207–665) | 333 ± 82.8 (330; 186–700) | −68.2 ± 106.1 (−66.5; −97–479) | 328.5 ± 100.9 (320; 186–770) | −72.4 ± 119.9 (−58; −210–476) | <0.0001 |
|
|
Legend: VA = visual acuity, CRT = central subfield retinal thickness.
|
